Evidence map›Paper›PMID 30023707›Full record

ArticleACS omega2017

Small-Molecule Inhibitors of the NusB-NusE Protein-Protein Interaction with Antibiotic Activity.

Peter J Cossar, Mohammed K Abdel-Hamid, Cong Ma, Jennette A Sakoff, Trieu N Trinh, Christopher P Gordon, Peter J Lewis, Adam McCluskey

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Ligand-Based Drug Design of Novel Antimicrobials againstInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Peter J CossarChemistry, School of Environmental & Life Sciences and Biology, Centre for Chemical Biology and Clinical Pharmacology, School of Environmental & Life Sciences, The University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Mohammed K Abdel-HamidChemistry, School of Environmental & Life Sciences and Biology, Centre for Chemical Biology and Clinical Pharmacology, School of Environmental & Life Sciences, The University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Cong MaChemistry, School of Environmental & Life Sciences and Biology, Centre for Chemical Biology and Clinical Pharmacology, School of Environmental & Life Sciences, The University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Jennette A SakoffExperimental Therapeutics Group, Department of Medical Oncology, Calvary Mater Newcastle Hospital, Edith Street, Waratah, NSW 2298, Australia.
Trieu N TrinhChemistry, School of Environmental & Life Sciences and Biology, Centre for Chemical Biology and Clinical Pharmacology, School of Environmental & Life Sciences, The University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Christopher P GordonNanoscale Organization and Dynamics Group, School of Science and Health, University of Western Sydney, Penrith South DC, NSW 2751, Australia.
Peter J LewisChemistry, School of Environmental & Life Sciences and Biology, Centre for Chemical Biology and Clinical Pharmacology, School of Environmental & Life Sciences, The University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Adam McCluskeyChemistry, School of Environmental & Life Sciences and Biology, Centre for Chemical Biology and Clinical Pharmacology, School of Environmental & Life Sciences, The University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
University of Newcastle Australia · AUAssiut University · EGCalvary Mater Newcastle Hospital · AUWestern Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The NusB-NusE protein-protein interaction (PPI) is critical to the formation of stable antitermination complexes required for stable RNA transcription in all bacteria. This PPI is an emerging antibacterial drug target. Pharmacophore-based screening of the mini-Maybridge compound library (56 000 molecules) identified

Identifiers

PMID30023707
PMCPMC6044933
OpenAlexW2739420248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.